Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Erik Elias"'
Autor:
Sinan Karakaya, Lisa Gunnesson, Erik Elias, Paula Martos-Salvo, Mercedes Robledo, Ola Nilsson, Bo Wängberg, Frida Abel, Sven Påhlman, Andreas Muth, Sofie Mohlin
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors. PGLs can further be divided into sympathetic (sPGLs) and head-and-neck (HN-PGLs). There are virtually no treatment options, and no cure, for metastatic PCCs a
Externí odkaz:
https://doaj.org/article/bab3867431174edda96dfadd196f72e5
Autor:
Bilal Almobarak, Vishal Amlani, Linda Inge, Tobias Hofving, Andreas Muth, Ola Nilsson, Martin Johansson, Yvonne Arvidsson, Erik Elias
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Small intestinal neuroendocrine tumors (SI-NET) are highly differentiated and genetically stable malignant tumors, yet they often present with advanced metastatic spread at the time of diagnosis. In contrast to many other types of
Externí odkaz:
https://doaj.org/article/d055bd62c17549389cf2301a57fd0067
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine
Autor:
Erik Elias, Arman Ardalan, Markus Lindberg, Susanne E. Reinsbach, Andreas Muth, Ola Nilsson, Yvonne Arvidsson, Erik Larsson
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-8 (2021)
Small intestine neuroendocrine tumors (SI-NETs) are frequently multifocal and metastatic, but their tumourigenesis is still poorly understood. Here, the authors analyse multifocal SI-NET tumours with whole-genome sequencing, revealing the landscape o
Externí odkaz:
https://doaj.org/article/123fb58011ff4c5299d20a2fa8383e2b
Autor:
Tobias Hofving, Erik Elias, Anna Rehammar, Linda Inge, Gülay Altiparmak, Marta Persson, Erik Kristiansson, Martin E. Johansson, Ola Nilsson, Yvonne Arvidsson
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Patients with small intestinal neuroendocrine tumors (SINETs) frequently present with lymph node and liver metastases at the time of diagnosis, but the molecular changes that lead to the progression of these tumors are largely unk
Externí odkaz:
https://doaj.org/article/110de40eae1b4d18802b69af24c99a76
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Erik Elias, Johanna Svensson, Anders Bergström, Ola Nilsson, Peter Bernhardt, Viktor Johanson, Ida Marin, Anna-Karin Elf, Bo Wängberg
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2035, p 2035 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2035, p 2035 (2021)
Simple Summary Small intestinal neuroendocrine tumors (SI-NETs) are slow growing tumors expressing somatostatin receptors (SSTR), which are targeted in diagnostic and therapeutic methods. A fairly new treatment that targets SSTR2 is peptide receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1259d52b612fda1604c795cdb5da7a6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine
Autor:
Erik Larsson, Susanne Reinsbach, Erik Elias, Ola Nilsson, Andreas Muth, Arman Ardalan, Yvonne Arvidsson, Markus Lindberg
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-8 (2021)
Nature Communications
Nature Communications
Small intestine neuroendocrine tumor (SI-NET), the most common cancer of the small bowel, often displays a curious multifocal phenotype with several tumors clustered together in a limited intestinal segment. SI-NET also shows an unusual absence of dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14953aeba2b0ff654cef610a5aedf31a
https://doi.org/10.1101/2020.05.06.080499
https://doi.org/10.1101/2020.05.06.080499
Autor:
Anna-Karin Elf, Viktor Johanson, Ida Marin, Anders Bergström, Ola Nilsson, Johanna Svensson, Bo Wängberg, Peter Bernhardt, Erik Elias
Purpose Small intestinal neuroendocrine tumours (SI-NET) often present with distant metastases at diagnosis. Peptide receptor radiotherapy (PRRT) with radiolabelled somatostatin analogues is a systemic treatment that increases overall survival (OS) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::858fe95705652961d00cc42019060ef6
https://doi.org/10.21203/rs.2.21978/v1
https://doi.org/10.21203/rs.2.21978/v1
Autor:
Emma, Erik Elias, Bauke Haisma, Fiona M. Gribble, Erik Elebring, Carel W. le Roux, Neil G. Docherty, Ville Wallenius, Pierre Larraufie, Frank Reimann, Anna Casselbrant, Lars Fändriks
Publikováno v:
Gut
Gut, BMJ Publishing Group, 2019, 69, pp.1423-1431. ⟨10.1136/gutjnl-2019-319372⟩
Gut, BMJ Publishing Group, 2019, 69, pp.1423-1431. ⟨10.1136/gutjnl-2019-319372⟩
ObjectiveFood intake normally stimulates release of satiety and insulin-stimulating intestinal hormones, such as glucagon-like peptide (GLP)-1. This response is blunted in obese insulin resistant subjects, but is rapidly restored following Roux-en-Y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f66faba1d55026dcf7a10d07a91067ed
https://hal.archives-ouvertes.fr/hal-03208843/document
https://hal.archives-ouvertes.fr/hal-03208843/document